Thomas Lietman, MD



Trachoma, Childhood Mortality, and Corneal Ulcer Treatment and Prevention

Dr. Lietman is the Ruth Lee and Phillips Thygeson Distinguished Professor in the Department of Ophthalmology and Department of Epidemiology & Biostatistics, and the Director of the Francis I. Proctor Foundation. His research group has considerable experience with individual and community-randomized trials of trachoma, childhood mortality, and corneal ulcer treatment and prevention. He has served as the PI on a number of NIH-funded clinical trials: the Steroids for Corneal Ulcer Trial, the two Mycotic Ulcer Treatment Trials, the two Trachoma Amelioration in Northern Amhara studies, and the Village Integrated Eye Worker trial (in Nepal). He is multiple PI on the Ethiopian trachoma trial KETFO and on the ongoing SCUT II corneal ulcer trial. In addition, he was the overall PI on the Bill and Melinda Gates Foundation-funded MORDOR I study and for the MORDOR II studies (Niger and Burkina Faso), as well as the AVENIR planning grant (Niger). He ran the Niger arm of the BMGF-funded PRET trachoma study, and has worked on the BMGF-funded Neglected Tropical Disease modeling consortium. Recently, he has explored big data for infectious disease, including two NEI projects: the Digital Disease Detection grant and the Forecasting Trachoma grant.


To Learn More:


Research Areas:

Trachoma, Cornea, Infectious Diseases
Learn more about UCSF Ophthalmology faculty research.